XYD198 | MedChemExpress (MCE)

XYD198 (Compound 14h) is an orally active degrader for CBP/p300. XYD198 inhibits CBP/p300 bromodomain with IC₅₀ of 213.5 nM. XYD198 exhibits antitumor activity against acute myeloid leukemia. (Structure: Pink, CBP/p300 ligand 4 (HY-161495); Blue, E3 ligase ligand (HY-14658); Black: linker (HY-161499))^[1]

Price Not Available 1 mg XYD198 | MedChemExpress (MCE) Supplier Page

Trivial name	XYD198
Catalog Number	HY-161498
Research Area	Cancer
Purity	≥98.0%
SMILES	O=C1CCC[C@H](N1C2=CC=C(C(F)=C2)F)C3=NC4=C(C=CC(C5=C(ON=C5C)C)=C4)N3C6CCN(CC6)CC(NC7=CN=C(N=C7)C8=CC=C(C=C8)CNC9=CC=CC(C(N%10C%11C(NC(CC%11)=O)=O)=O)=C9C%10=O)=O
Size	1 mg
Supplier Page	https://www.medchemexpress.com/xyd198.html